German Version German Version
  Accessibility    Contact MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    Vienna General Hospital (AKH Wien)  
 
 
 
 
General Information / Team / Judit Simon
 

Judit Simon, MD, BA, BSc, MSc, DPhil, FFPH

Professor of Health Economics

Head of Department

Deputy Head of Center

Coordinator Doctoral Programme Public Health 

Phone: +43 1 40160 - 34841

E-Mail: judit.simon@muv.ac.at

Location: Kinderspitalgasse 15, 1st floor, room 138

Judit Simon is Professor of Health Economics and Head of the Department of Health Economics. She also holds the functions of Deputy Head of the Centre for Public Health and Coordinator of the Doctoral Programme Public Health at the Medical University of Vienna.

Her other current affiliations include:

- Head of Health Economics, Ludwig Boltzmann Institute Applied Diagnostics;
- Visiting Professor of Cognitive Health Economics at the Department of Psychiatry, University of Oxford; and
- Research Associate of the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford.

She previously held appointments at the UK National Collaborating Centre for Mental Health, University College London (UCL), the London School of Economics and Political Science (LSE); the Institute of Psychiatry, King’s College London; the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford; and the Oxford Health NHS Foundation Trust.

Professor Simon holds a DPhil in Public Health from the University of Oxford; an MSc in Health Economics from the University of York; and a Doctor of Medicine (MD), a BSc in Economics and a BA in Medical Translation from the University of Szeged. She is Fellow through Distinction of the UK Faculty of Public Health (FFPH).

Her work focuses on applied and methodological research in health economics and public health. Main expertise include economic evaluation in health and medicine, planning and conducting clinical studies/RCTs, clinical guideline development, health services research, health systems research, outcomes/effectiveness research, cost and economic burden studies, and evidence synthesis. Specific research areas lie in the fields of mental health, public health, nutrition, cancer and chronic diseases, personalised medicine and translational research, capabilities and costing methods.


Selected Bibliography

  • Brodszky V, Beretzky Z, Baji P, Rencz F, Péntek M, Rotar A, Tachkov K, Mayer S, Simon J, Niewada M, Hren R, Gulacsi L. (2019): Cost-of-illness studies in Central and Eastern European countries. European Journal of Health Economics, 20 (Suppl 1):155–172. doi: 10.1007/s10198-019-01066-x
  • Laszewska A, Wancata J, Jahn R, Simon J: The excess economic burden of mental disorders: findings from across-sectional prevalence survey in Austria. European Journal of Health Economics 
  • Simon J (2019): Ökonomische Konsequenzen. In: Novotny, M, Kern, D, Breyer, E, Bengough, T, Griebler, R (Hg.): Depressionsbericht Österreich. Eine interdisziplinäre und multiperspektivische Bestandsaufnahme. Bundesministerium für Gesundheit und Frauen (BMGF): Wien, pp 135-141.
  • Lim, MS, Beyer, T, Babayan,A, Bergmann, M, Brehme, M, Buyx, A, Czernin, J, Egger, G, Elenitoba-Johnson, KSJ, Gückel, B, Jačan, A, Haslacher, H, Hicks, RJ, Kenner, L, Langanke, M Mitterhauser, M, Pichler, BJ, Salih, HR, Schibli, R, Schulz, S, Simecek, J, Simon, J, Soares,MO, Stelzl, U, Wadsak, W, Zatloukal, K, Zeitlinger, M, Hacker, M (2019): Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria. Molecular Imaging and Biology, Special Topic, pp 1-19. DOI: 10.1007/s11307-019-01361-2
  • Łaszewska A, Schwab M, Leutner E, Oberrauter, M, Spiel, G, Simon, J (2019): Measuring broader wellbeing in mental health services: validity of the German language OxCAP-MH capability instrument. Quality of Life Research: 28(8):2311-2323, DOI:10.1007/s11136-019-02187-9
  • Mayer S, Spickschen J, Stein KV, Crevenna R, Dorner TE, Simon J (2019): The societal costs of chronic pain and its determinants: the case of Austria. PLoS ONE, 14(3):e0213889. DOI: doi.org/10.1371/journal.pone.0213889
  • Grössmann, N,  Robausch, M,  Rosian, K, Wild, C, Simon, J (2019): Monitoring evidence on overall survival benefits of anti-cancer drugs approved by the European Medicines Agency between 2009 and 2015. European Journal Of Cancer. European Journal of Cancer. (110): 1-7. DOI: 10.1016/j.ejca.2018.12.026
  • Simon J, Geddes JR, Gardiner A, Rendell J, Goodwin GM, Mayer S (2018): Comparative economic evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression (CEQUEL). Bipolar Disorder. 20(8):733-745. doi.org/10.1111/bdi.12713
  • Cheung KL, Mayer S, Simon J, de Vries H, Evers S, Kremer I, Hiligsmann M (2019): Comparison of statistical analysis methods for object case best-worst scaling. Journal of Medical Economics, 22(6):509–515. doi.org/10.1080/13696998.2018.1553781
  • Niedersüß-Beke D, Simon J, Schiffinger M, Mader RM. (2018): Economic analysis of biomarker-based anti-EGFR therapies in metastatic colorectal cancer in the Austrian context. MEMO Magazine of European Medical Oncology, (11: 322), 1-8. doi: 10.1007/s12254-018-0440-y  
  • Perić N, Hofmarcher-Holzhacker M M, Simon J (2018): Headline indicators for monitoring the performance of health systems: Findings from the european Health Systems_Indicator (euHS_I) survey. Archives of Public Health. 76: 32. doi:  10.1186/s13690-018-0278-0
  • Köppen P, Dorner T, Stein K, Simon J, Crevenna R. (2018): Health literacy, pain intensity and pain perception in patients with chronic pain. Wiener Klinischen Wochenschrift, 130(1): 23–30. DOI: 10.1007/s00508-017-1309-5
  • Simon J, Łaszewska A, Leutner E, Spiel G, Churchman D, Mayer S (2018): Cultural and linguistic transferability of the multi-dimensional OxCAP-MH capability instrument for outcome measurement in mental health: the German language version. BMC Psychiatry, 18(1):173.
  • Batóg P, Rencz F, Péntek M, Gulácsi L, Filipiak KJ, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Golicki D. (2018) EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature. Kardiol Pol. 2018 Jan 19. doi: 10.5603/KP.a2018.0033. [Epub ahead of print] PubMed PMID: 29350378
  • Łaszewska A, Österle A, Wancata J, Simon J (2018). Prevalence of mental diseases in Austria: systematic review of the published evidence. Wiener Klinische Wochenschrift, 130(3-4): 141-150. DOI: 10.1007/s00508-018-1316-1
  • Simon J (2018): Public Health Economics: Gesundheitsökonomie zur Gesundheitsförderung und Krankheitsvorbeugung. Gesundheit 2017. Jahrbuch für Gesundheitspolitik und Gesundheitswirtschaft in Österreich. Sanofi 2017, 9. Ausgabe, Pages 64-65.
  • Hofmarcher MM, Perić N, Simon J. (2017) Headline indicators for structured monitoring of health system performance in Europe. Eurohealth, 23(4): 11-15
  • Vergunst F, Jenkinson C, Burns T, Anand P, Gray A, Rugkåsa J, Simon J (2017). Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH). Health and Quality of Life Outcomes, 15:250. DOI: 10.1186/s12955-017-0825-3
  • Simon J, Łaszewska A, Leutner E, Churchman D, Mayer S (2017): Inter-country Transferability of the OxCAP-MH Well-being Questionnaire. J Ment Health Policy Econ 2017; 20(Suppl. 1): S31
  • Kingslake J, Dias R, Dawson GR, Simon J, Goodwin GM, Harmer CJ, et al. (2017) The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: Study Protocol for a Randomised Controlled Trial. Trials. DOI: 10.1186/s13063-017-2247-2
  • Vergunst F, Rugkåsa J, Koshiaris C, Simon J, Burns T (2017). Community treatment orders and social outcomes for patients with psychosis: a 48-month follow-up study. Social Psychiatry and Psychiatric Epidemiology, 52(11), 1375-1384, Nov 2017. DOI: 10.1007/s00127-017-1442-5
  • Feig C, Cheung KL, Hiligsmann M, Evers S, Simon J, Mayer S (2018): Best-worst scaling to assess the most important barriers and facilitators for the use of Health Technology Assessment in Austria. Expert Review of Pharmacoeconomics & Outcomes Research. 18(2), 223-232.
  • Zrubka Z, Rencz F, Závada J, Golicki D, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Petrova G, Rotar A, Gulácsi L, Péntek M (2017): EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis. Rheumatology International, 37(12), 1957–1977, Dec 2017. DOI: 10.1007/s00296-017-3800-8
  • Mayer S, Kiss N, Łaszewska A, Simon J (2017): Costing evidence for health care decision-making in Austria: A systematic review. PLOS ONE, 12(8): e0183116. DOI: 10.1371/journal.pone.0183116.
  • Hofmarcher M M, Simon J, Haidinger G (2017): Stroke-units in Austria: incubators for improved health outcomes. in Braithwaite J. et al (Ed) Health Systems Improvement Across the Globe: Success Stories from 60 Countries, CRC Press.
  • Simon J, Budge K, Price J, Goodwin G M, Geddes J R (2017): Remote mood monitoring for adults with bipolar disorder: an explorative study of compliance and impact on mental health service use. European Psychiatry, 45C, pp. 14-19. DOI: 10.1016/j.eurpsy.2017.06.007. 
  • Mayer S, Paulus A, Łaszewska A, Simon J, Drost R, Ruwaard D, Evers S. (2017): Health-related resource-use measurement items for intersectoral costs and benefits (ICBs) in the education and criminal justice sector: systematic review of instruments. PharmacoEconomics, 35(9), 895-908. DOI: 10.1007/s40273-017-0522-4.
  • Bogaert P, Van Oyen H for BRIDGE Health (Hofmarcher M M, Simon J, Perić N) (2017). HIREP-ERIC: A research infrastructure to advance public health monitoring and research on health and care. Technical and Scientific Description, BRIDGE Health Technical Report 03/2017, Scientific Institute of Public Health, Brussels, March 2017.
  • Bogaert P, Van Oyen H for BRIDGE Health (Hofmarcher M M, Simon J) (2017). An ERIC on Health Information for Research and Evidence-based Policy for targeted investments in people's health and wealth, BRIDGE Health policy paper, Scientific Institute of Public Health, Brussels, January 2017.
  • Hofmarcher-Holzhacker M, Perić N, Simon J (2017): Schlüsselindikatoren für eine strukturierte Bewertung der Leistungsfähigkeit von Gesundheitssystemen in Europa: ein Fortschrittsbericht des EU Projekts BRIDGE Health. ÖGPH Newsletter March 2017
  • Hofmarcher M M, Perić N, Simon J on behalf of the BRIDGE Health working group for horizontal activity 6 (2017). Priority setting methods in health information, BRIDGE Health Technical Report 04/2017 on Recommendations of priority setting methods for a European Research Infrastructure Consortium on Health Information for Research and Evidence-based policy (HIREP-ERIC), HS&I and Medical University of Vienna, April 2017.
  • Perić N, Hofmarcher-Holzhacker M M, Simon J (2017): Health system performance assessment landscape at the EU level: A focused synthesis of actors and actions. Archives of Public Health, 75(5). DOI: 10.1186/s13690-016-0173-5.
  • Hofmarcher M M, Perić N, Simon J, Joas A, Bogaert P (2016). Priority setting methods and transferability in health information. Adjacent Government.
  • Burns T, Rugkåsa J, Yeeles K, Catty J, on behalf of the Oxford Mental Health Coercion (OCTET) Programme Group (Simon J) (2016): Coercion in mental health: a trial of the effectiveness of community treatment orders and an investigation of informal coercion in community mental health care. Programme Grants Appl Res, 4(21). DOI: 10.3310/pgfar04210.
  • Mayer S, Vogler S, Simon J, Österle A. Exploring determinants of polypharmacy in the elderly population in Austria. Value in Health, Volume 19, Issue 7, November 2016, Page A451
  • Mayer S, Kiss N, Łaszewska A, Simon J. Health Economic Costing Methods and Reporting in Austria. Value in Health, Volume 19, Issue 7, November 2016, Page A363
  • Golicki D, Péntek M, Gulácsi L, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Zrubka Z, Závada J, Petrova G, Rotar A, Rencz F. EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries. Value in Health, Volume 19, Issue 7, November 2016, Pages A657-A658
  • Péntek M, Rencz F, Golicki D, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Zrubka Z, Petrova G, Rotar A, Gulácsi L. EQ-5D Studies in Rheumatology in Eight Central and Eastern European Countries. Value in Health, Volume 19, Issue 7, November 2016, Page A542
  • Prevolnik Rupel V, Turk E, Péntek M, Rencz F, Golicki D, Simon J, Brodszky V, Baji P, Zrubka Z, Zavada J, Petrova G, Rotar A, Gulacsi L. Eq-5d Studies In Nervous System Diseases In Eight Central And Eastern European Countries. Value in Health, Volume 19, Issue 7, November 2016, Page A471
  • Bilderbeck AC, Atkinson LZ, McMahon HC, Voysey M, Simon J, Price J, Rendell J, Hinds C, Geddes JR, Holmes E, Miklowitz DJ, Goodwin GM (2016) Psychoeducation and online mood tracking for patients with bipolar disorder: A randomised controlled trial. Journal of Affective Disorders, 205:245-251. DOI: 0.1016/j.jad.2016.06.064.
  • Rencz F, Gulácsi L, Drummond M, Golicki D, Prevolnik Rupel V, Simon J, Stolk EA, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Péntek M (2016) EQ-5D in Central and Eastern Europe: 2000-2015. Quality of Life Research, 19(5):525-530. DOI: 10.1007/s11136-016-1375-6
  • Barnes TRE, Leeson VC, Paton C, Costelloe C, Simon J, Kiss N, Osborn D, Killaspy H, Craig TKJ, Lewis S, Keown P, Ismail S, Crawford M, Baldwin D, Lewis G, Geddes J, Kumar M, Pathak R, Taylor S (2016) Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial. Health Technology Assessment, 20(29). DOI: 10.3310/hta20290.
  • Geddes J, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, Yu L-M, Hainsworth J, Attenburrow M-J, Simon J, Goodwin G, Harrison P (2016) Comparative evaluation of quetiapine-lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression: a 2x2 factorial randomised trial (CEQUEL). The Lancet Psychiatry, 3(1):31–39. DOI: 10.1016/S2215-0366(15)00450-2.
  • Simon, J. (2016). Determinanten von Gesundheit und Gesundheitsversorgung. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 4. Auflage, Wien
  • Simon, J. (2016). Gesundheitsökonomische Evaluation II. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 4. Auflage, Wien
  • Simon, J (2015). Determinanten von Gesundheit und Gesundheitsversorgung. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 3. Auflage, Wien
  • Simon, J (2015). Gesundheitsökonomische Evaluation II. In: Dorner, T.E. (ed.). Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. MCW Block 22/23. Facultas Verlags- und Buchhandels AG: 3. Auflage, Wien
  • Rugkåsa J, Molodynski A, Yeeles K, Vazquez Montes M, Visser C, Burns T, Bennett C and the OCTET group (Burns K, Burns T, Canvin K, Dawson J, Dunn M, Gray A, Johnston L, Lewis N, Masson S, Molodynski A, Murray L, Nightingale H, Patel R, Priebe S, Puntis S, Russell L, Ryan A, Simon J, Sinclair J, Smith T, Sulman A, Turnpenny L, Mitchell A, Montes MV, Vergunst F, Visser C, Wood-Ganz S, Voysey M, Yeeles K) (2015) Community treatment orders: Clinical and social outcomes, and a subgroup analysis from the OCTET RCT. Acta Psychiatrica Scandinavia, 131(5):321-329. DOI 10.1111/acps.12373
  • Pari AA, Simon J, Wolstenholme J, Geddes J, Goodwin G (2015) Economic burden of bipolar disorder in the United Kingdom: a patient-level exploratory analysis. Bipolar Disorders, 17:138.
  • Hofmarcher-Holzhacker M, Simon J, Peric N (2015) Kick off neue Projekte - BRIDGE Health: Bridging Information and Data Generation for Evidence-based Health Policy and Research. ÖGPH Newsletter September 2015, pp. 11-12.
  • Simon J, Kiss N, Łaszewska A, Mayer S (2015) Public health aspects of migrant health: a review of the evidence on health status for labour migrants in the European Region. WHO Health Evidence Network Synthesis Report 43. ISBN 978 92 890 5109 5
  • Simon J, Gray A, Mayer S, Ł aszewska A, Rugkåsa J, Yeeles K, Burns T (2015) Cost-effectiveness of Community Treatment Orders (CTOs): Economic Evaluation of the OCTET Study. Journal of Mental Health Policy and Economics, 18 (S1): S36.
  • Steel C, van der Gaag M, Korrelboom K, Simon J, Phiri P, Baksh M F, Wykes T, Rose D, Rose S, Hardcastle M, Enright S, Evans G, Kingdon D (2015) A randomised controlled trial of positive memory training for the treatment of depression within schizophrenia, BMC Psychiatry 15:85 doi:10.1186/s12888-015-0453-6.
  • Simons CL, Rivero-Arias O, Yu LM, Simon J (2015) Multiple imputation to deal with missing EQ-5D-3L data - should we impute individual domains or the actual index?, Quality of Life Research, doi: 10.1007/S11136-014-0837-Y
  • Vergunst, F., Jenkinson, C., Burns, T. & Simon, J. (2014) Application of Sen's Capability Approach to Outcome Measurement in Mental Health Research: Psychometric Validation of a Novel Multi-dimensional Instrument (OxCAP-MH). Human Welfare 3, 1, 1-4.
  • Abdul Pari Anees A, Simon Judit, Wolstenholme Jane, Geddes John R, and Goodwin Guy M (2014) Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disorders, Volume 16, Issue 6, pages 557–582. doi: 10.1111/bdi.12213.
  • Simon Judit, Anand Paul, Gray Alastair, Rugkåsa Jorun, Yeeles Ksenija, and Burns Tom (2013) Operationalising the capability approach for outcome measurement in mental health research Social Science & Medicine, 98:187–196. doi: 10.1016/ j.socscimed.2013.09.019
  • Miklowitz David J, Price Jonathan, Holmes Emily A, Rendell Jennifer, Bell Sarah, Budge Katie, Christensen Jean, Wallace Joshua, Simon Judit, Armstrong Neil M, McPeake Lily, Goodwin Guy M, and Geddes John R (2012) Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar Disorder Mar 2012; 14(2): 185–197. doi:  10.1111/j.1399-5618.2012.00998.x
  • Simon J, Budge KV, Goodwin G, Geddes J. (2011) Health economic preparatory work for OXTEXT: The development and evaluation of cost-effective systems of collaborative disease management for people with bipolar disorder. Journal of Mental Health Policy and Economics, 14(Suppl.1): S32.
  • Farmer A J, Wade A N, French D P, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman R R, Mant D, Kinmonth A-L, and Neil H AW (2009) Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.
  • Simon J, Petrou S, Gray A. (2009) The valuation of prenatal life in economic evaluations of perinatal interventions. Health Economics, 18(4): 487-494.
  • Simon J, et al. (2009) A vércukorszint otthoni monitorozásának költséghatékonysága 2-es típusú cukorbetegségben. Lege Artis Medicinae, 19(1): 45.
  • Simon, J, Gray, A, Wade, A, Neil, A, Farmer, A, on behalf of the Diabetes Glycaemic Education and Monitoring Trial Group. (2008) Cost-effectiveness of self-monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. British Medical Journal, 336: 1177-1180. doi: 10.1136/bmj.39526.674873.BE
  • Zechmeister I, Kilian R, McDaid D, the MHEEN group (2008) Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations. BMC Public Health, 8: 20.
  • Knapp M, McDaid D, Evers S, Salvador-Carulla L, Halstein V, the MHEEN group. (2008) Cost-effectiveness and Mental Health, MHEEN II Policy Briefing 2, Personal Social Services Research Unit, London.
  • McDaid D, Knapp M, Medeiros H, the MHEEN group. (2008) Employment and Mental Health: Assessing the Economic Impact and the Case for Intervention, MHEEN II Policy Briefing 5. Personal Social Services Research Unit, London.
  • McDaid D, Zechmeister I, Kilian R, Medeiros H, Knapp M, Kennelly B, the MHEEN group. (2008) Making the Economic Case for the Promotion of Mental Well-being and the Prevention of Mental Health Problems, MHEEN II Policy Briefing 3. Personal Social Services Research Unit, London.
  • Medeiros H, McDaid D, Knapp M, the MHEEN group. (2008) Shifting Care from Hospital to the Community in Europe: Economic Challenges and Opportunities, MHEEN II Policy Briefing 4. Personal Social Services Research Unit, London.
  • Knapp M, McDaid D, Medeiros H, Becker T, Johnson S, Kilian R, Salvador-Carulla L, Simon J, Tatar M, on behalf of the MHEEN group. (2008) Economics, Mental Health and Policy: An Overview, MHEEN II Policy Briefing 1. Personal Social Services Research Unit, London.
  • MAGPIE Trial Follow Up Study Collaborative Group. (2007) The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG-INT J OBSTET GY, 114(3): 289-299.
  • MAGPIE Trial Follow Up Study Collaborative Group. (2007) The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG-INT J OBSTET GY, 114(3): 300-309.
  • McDaid D, Knapp M, Medeiros H, the MHEEN group. (2007) Mental health and economics in Europe. Findings from the MHEEN group. Eurohealth, 13(3): 1-6.
  • Simon J, Gray A, Wade A, et al. (2007) Cost-effectiveness of self-monitoring of blood glucose for the management of patients with non-insulin treated type 2 diabetes: economic evaluation of the DiGEM trial. Diabetologia, 50(Suppl.1): S431.
  • Simon J, Pilling S, Goldberg D, Burbeck R. (2006) Treating moderate and severe depression with antidepressant therapy or combination of antidepressants and psychological therapy: a decision analysis supporting a clinical guideline. British Journal of Psychiatry, 189: 494-501.
  • Clarke PM, Simon J, Cull CA, Holman RR. (2006) Assessing the impact of visual acuity on quality of life in people with type 2 diabetes using the SF-36. Diabetes Care, 29: 1506-1511.
  • Simon J, Gray A, Duley L, on behalf of the MAGPIE Trial Collaborative Group. (2006) Cost effectiveness of prophylactic magnesium sulphate in 9996 women with pre-eclampsia from 33 countries: Economic evaluation of the Magpie Trial. BJOG, 113: 144-151.
  • Gervain J, Simon J, Czibula A, et al. (2006) The correlation of genom mutations in HCV-1b with IFN-sensitivity in Hungarian patients. Journal of Gastroenterology and Hepatology, 21(Suppl.2): A139-A139.
  • Simon J, Patel A, Sleed M. (2005) The costs of alcoholism. Journal of Mental Health, 14(4): 321-330.
  • Simon J, Schmidt U, Pilling S, on behalf of the Eating Disorders Guideline Development Group. (2005) The health service use and cost of eating disorders. Psychological Medicine, 35(11): 1543-1551.
  • National Collaborating Centre for Mental Health. (2004) Depression: management of depression in primary and secondary care. Clinical Guideline 23. NICE: London.
  • Knapp M, Mangalore R, Simon J. (2004) The global costs of schizophrenia. Schizophrenia Bulletin, 30: 279-293.
  • Petrou S, Boulvain M, Simon J, Maricot P, Borst F, Irion O. (2004) Home-based care after a shortened hospital stay versus hospital-based care postpartum: An economic evaluation. BJOG, 111: 800-806.
  • National Collaborating Centre for Mental Health. (2004) Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. Clinical Guideline 9. NICE: London.
  • National Collaborating Centre for Mental Health. (2004) Depression: management of depression in primary and secondary care. National Clinical Practice Guideline CG23. Gaskell Press: London.
  • Richardson G, Wonderling D, Simon J, Wailoo A, Douglas HR, Culyer AJ, Tsuchiya A, Roberts J, Drummond MF, on behalf of the Health Economists in Guidelines group. (2004) Incorporating health economics in guidelines and assessing resource impact. In: NICE. Guideline development methods: Information for National Collaborating Centres and Guideline Developers. NICE: London.  
  • National Collaborating Centre for Mental Health. (2004) Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. National Clinical Practice Guideline CG9. Gaskell Press: London.
  • Gervain J, Simon G, Simon J, the Hungarian Viral Hepatitis Group. (2003) Genotype distribution of hepatitis C virus in the Hungarian population with chronic viral hepatitis C. European Journal of Gastroenterology and Hepatology, 15(4): 449-450.
  • Gervain J, Czibula A, Simon J, Kalmar T. (2003) Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity. Orvosi Hetilap, 144: 1179-1184.
  • National Collaborating Centre for Mental Health. (2003) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. National Clinical Practice Guideline CG1. Gaskell Press: London.
  • Simon J. (2003) Cost-conscious clinical guidelines: the schizophrenia guideline example. Mental Health Research Review, 9:42-43.
  • Simon J, Whittington C, on behalf of the Eating Disorders Guideline Development Group. (2003) Cost-effectiveness of antidepressant therapy, cognitive behaviour therapy and their combination for people with bulimia nervosa in the UK. Value in Health, 6(6): A619-A620.  
  • National Collaborating Centre for Mental Health. (2002) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical guideline 1. NICE: London.
  • Knapp M, Simon J. (2002) Cost implications of schizophrenia in the community. Psychiatry, 1(10): 69-72.
  • Knapp M, Simon J, Almond S, Percudani M. (2002) Costs of Schizophrenia: A Review. In: Maj M. (ed.) Schizophrenia (2nd ed). John Wiley & Sons Ltd.: Chichester.
  • Gervain J, Czibula A, Kalmar T, Simon J, Papp I, Szabo KB. (2002) Mutations of the NS5A domain of HCV subtype 1b and response to interferon therapy in Hungarian patients. Zeitschrift fuer Gastroenterologie, 40: A334.
  • Balati B, Jost N, Simon J, Varro A, Papp JGy. (2000) Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent in canine isolated ventricular muscle and Purkinje fibres. General Pharmacology, 34(2): 85-93.
  • Baláti B, Iost N, Simon J, Varró A, Papp JGy. (2000) Az ambasilid, egy antiaritmiás szer elektrofiziológiai hatásainak vizsgálata izolált kutyaszív preparátumokon. Cardiologia Hungarica, Suppl 3: S46.
  • Baláti B, Takács J, Iost N, Virág L, Simon J, Varró A, Papp JGy. (1999) The role of the slow component of the delayed rectifier potassium current in dog ventricular muscle and Purkinje fibre repolarization. Fundamental and Clinical Pharmacology, 13(Suppl 1): S226.
  • Baláti B, Takács J, Iost N, Virág L, Simon J, Varró A, Papp JGy. (1999) A "delayed rectifier" káliumáram lassú komponensének szerepe a kutyaszív kamrai munkaizom és Purkinje rostjainak repolarizációjában. Cardiologia Hungarica, Suppl 2: S19.
  • Baláti B, Simon J, Varró A, Papp JGy. (1998) Cellular electrophysiological effects of chromanol 293B in canine ventricular muscle. Journal of Molecular and Cellular Cardiology, 30: A133.
 
Drucken
 

Quick Links

 
 

Featured

 
 
 
 
 
© MedUni Wien | Publishing information | Terms of use | Contact